Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Biogen CEO Says Alzheimer's Uptake 'Is Delayed,' But Shares Pop On Earnings Beat
Investors Business Daily
Wed, 10/20/21 - 10:32 am
Tags:
Biogen, earnings, Aduhelm, Alzheimer's disease
Biogen, Sage plot 2022 filing for zuranolone approval, furthering turnaround of depression drug
Fierce Biotech
Tue, 10/19/21 - 11:54 am
Tags:
Biogen, SAGE Therapeutics, zuranolone, FDA, clinical depression
ANA 2021 – Ionis rocked by tofersen flop
EP Vantage
Mon, 10/18/21 - 10:58 am
Tags:
Biogen, Ionis Pharmaceuticals, clinical trials, ALS, tofersen
Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD1-ALS
Yahoo Finance
Sun, 10/17/21 - 11:04 pm
Tags:
Biogen, tofersen, clinical trials, ALS
Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination
PM Live
Wed, 10/13/21 - 10:47 am
Tags:
Biogen, MS, multiple sclerosis, COVID-19, vaccines
Why Humana Is Suing Biogen
Motley Fool
Sat, 10/9/21 - 11:04 pm
Tags:
Biogen, Medicare, Humana
Could Biogen's Blockbuster Hopes for Alzheimer's Disease Drug Aduhelm Be Doomed?
Motley Fool
Fri, 10/8/21 - 10:43 am
Tags:
Biogen, Aduhelm, Alzheimer's disease
Biogen, mRNA players on Merck's M&A radar as CEO still hungry for deals after $11.5B Acceleron buy: FT
Fierce Pharma
Wed, 10/6/21 - 11:26 pm
Tags:
Merck, M&A, Biogen, Mirati Therapeutics
Biogen and Sage Present Positive Data for Breakthrough Depression Therapy
BioSpace
Mon, 10/4/21 - 10:55 pm
Tags:
Biogen, SAGE Therapeutics, major depressive disorder, postpartum depression, clinical trials, zuranolone
Mass General Brigham vetoes controversial Alzheimer's drug Aduhelm after internal review
Fierce Healthcare
Fri, 10/1/21 - 10:41 am
Tags:
Massachusetts, hospitals, Biogen, Aduhelm, Alzheimer's disease
Despite rough start, Biogen's Aduhelm should find footing, analysts say. But don't expect much in 2021
Fierce Pharma
Wed, 09/29/21 - 11:58 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease
Seizing Aduhelm precedent, Biogen, Eisai get the ball rolling on another accelerated Alzheimer's approval
Endpoints
Tue, 09/28/21 - 12:07 am
Tags:
Biogen, Aduhelm, Eisai, Alzheimer's disease, FDA, lecanemab
Biogen used charity giving to illegally boost multiple sclerosis drug sales, Humana lawsuit says
Fierce Pharma
Mon, 09/27/21 - 11:04 am
Tags:
Biogen, Humana, multiple sclerosis, charity, legal
Do not enter: Biogen reps banned from D.C.-area neurology clinics over controversial Alzheimer's drug Aduhelm
Fierce Pharma
Wed, 09/22/21 - 11:40 pm
Tags:
Biogen, drug reps, Aduhelm, Alzheimer's disease
Struggling with Alzheimer's launch, Biogen couldn't present 'clear case for growth' outside of Aduhelm: analyst
Fierce Pharma
Wed, 09/22/21 - 12:03 pm
Tags:
Biogen, Alzheimer's disease, drug launches, Aduhelm
FDA approves first biosimilar to top-selling eye drug Lucentis
BioPharma Dive
Mon, 09/20/21 - 10:55 pm
Tags:
FDA, biosimilars, Lucentis, age-related macular degeneration, Byooviz, Biogen, Samsung Bioepis
Biogen's Non-Opioid Pain Drug Shines in Small Fiber Neuropathy Study
BioSpace
Fri, 09/17/21 - 11:01 am
Tags:
Biogen, small fiber neuropathy, clinical trials, vixotrigine
Biogen's Alzheimer's drug Aduhelm slowly gaining steam among prescribing neurologists, study finds
Fierce Pharma
Thu, 09/16/21 - 10:34 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease
Citing 'less-than-optimal' outcomes for Roche's Evrysdi, Biogen launches high-dose Spinraza trial
Fierce Pharma
Thu, 09/16/21 - 10:52 am
Tags:
Biogen, Spinraza, SMA, Roche, Evrysdi, spinal muscular atrophy
CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington's intensifying drug-pricing push
Fierce Pharma
Thu, 09/16/21 - 10:50 am
Tags:
drug pricing, Medicare, Pharma CEOs, Eli Lilly, AbbVie, Bristol Myers Squibb, Biogen, GSK

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.